Kelly is a 48-year-old female who suffers from plaque psoriasis (L40.0). Kelly’s symptoms include scattered, confluent papulosquamous plaques with silvery scale located on her scalp, buttocks, hands, arms ears, abodomen and legs. Kelly has tried and failed various treatments including numerous topicals, betamethasone, and Otezla. The denial letter states that Kelly does not have a history of failure, contraindication, or intolerance to Enbrel or Humira. However, Kelly has been on Stelara treatment waiting on authorization from insurance and is showing an overall relief of her symptoms for the first time in her life. It would be ill advised and completely unethical to discontinue the Stelara due to your denial as this medication is clearly
Eva and Maria entered into a written contract pursuant (a legal document) with Maria for rendering decorating services for a total price of $75,000.
Polypharmacy is the “concurrent use of several differ drugs and becomes an issue in older adults when the high number of drugs in a medication regimen includes overlapping drugs for the same therapeutic effect”(Woo & Wynne, 2011, p. 1426). The patient is currently taking several medications that can potential interact with each other, perform the same therapeutic effect, and creating side effects. The following is a list of her medications and their indications:
After review of the clinical information provided by North Central Bronx Hospital, the Medical Director has denied your admission to North Central Bronx Hospital. It was determined that the clinical information did not justify an inpatient stay. Acute inpatient hospitalization was not medically necessary. You are a 56 year old female with complaints of worsening pressure-like chest pain on the left sided that radiated to your left arm and neck. The symptoms began when you were at rest and woke you from your sleep. Based on the Interqual guideline (a decision based program to determine medical need) criteria to for acute coronary syndrome the clinical guidelines were not met because troponins were negative, there was no diagnostic testing such as a stress test, or documentation of ischemia in the clinical information that was submitted.
Today he chooses to have a healthy life and control his diabetes. He takes one medication orally for his diabetes, Metformin. JR has a good, healthy diet as well as exercise habits like taking walks with his dog. JR takes seven medication on the daily with three being for his heart, one for his high blood pressure, one for his cholesterol, one for his diabetes and another one to prevent blood clots. After making sure there was no drug to drug interaction between any of this medications, I informed my patient that his medication can not cure diabetes and high blood pressure but control
Although Pfizer was not required to warn the public and Kline, they were responsible for warning physicians. Pfizer dismissed Kline’s Complaints pursuant to Federal Rule of Civil Procedure 12(b)(6), which successfully dismissed Counts I and VII. Motion to Dismiss under Federal Rule of Civil Procedure 12(b)(6) “for failure to state a claim for which relief can be granted.” As the Plaintiff, Kline should have provided several sets of proof in order to support his claim and be granted the relief. Kline failed to provide the Fact Sheet and Authorization forms under the Joint Coordinate Plan.
This week we had an officer working whose S11 had expired in LMS. The officer reported to medical and complete his S11 examination prior to his expiration date. The officer was told by the medical staff that before they could complete his approval he needed to follow up with his primary care physician to confirm a pre-existing condition was being treated and controlled by the doctor. The officer was asked to have his primary care physician forward the documentation to TVA’s medical and once this was done they would sign off on the TVA documents completing the officers annual S11 evaluation. The officers asked the medical staff to send him an email with her request for the additional documentation for which she did. However the nurse never
Blanka Dobrynin is an activist investor that focuses on distressed companies, merger arbitrage, change of control transactions and recapitalizations. For recapitalizations she looks for inefficiencies in companies’ capital structure and gains returns through restructuring them with more efficient methods. She seeks firms that are stable and that have relatively low risk and little to no debt. She then uses the benefits of leverage, which provides more financial flexibility, a tax shield, and in some cases a higher market capitalization.
The claimant is a 25-year-old female who was injured in an industrial-related incident on 01/23/16. She presented with a work-related low back pain associated with a right lower extremity radiculopathy. The request is for Methyprednisolone. However, .there was no mention that the claimant had inflammation. Further, this medication was not part of her medication regimen nor part of the treatment plan. Also, as per cited guidelines, oral corticosteroids are “not recommended for chronic pain.
“The specific reason for this denial of your appeal for Harvoni is that coverage guidelines have not been met
...SDM) is appointed or there is insufficient time to contact the SDM, the health care professionals (HCP) must comply with the binding provisions. They state that the SDM’s must abide by a refusal stated in an ACD, if they believe it would be what the patient would of wanted in the current circumstances. They suggest that the SDM will then refuse on the patient’s behalf, and their consent/refusal is legally valid. Also if a patient has indicated health care that they would accept in their ACD, and if the treatment is clinically appropriate, the ACD is an indication of their consent (SA Health, 2014). ACD’s are normally written when a person is in good health, and are not always honoured as it is not unusual for a person to change their mind as their illness progresses; and therefore patient’s still retain the option of nullifying the document (Farrell & Dempsey, 2014).
would not deny his prescription; however, I would inform Jack that I am going to refill his Crestor medication for one month only to last until he is seen in the office. I would have Jack schedule an office visit within the month for assessment and lab work before hanging up the phone.
This information is in response to your request regarding Chantix as an ideal method for smoking withdrawal for your 54-year old female patient with Patient ID# 122014. Her medical profile shows that she has type II diabetes, hypertension, and major depression. I noticed that you replaced her lisinopril with olmesartan due to her dry cough in order to reduce her dry cough side effect. Additionaly, she has been taking fluoxetine since December 2004 to treat her long-term depression. She is also working on her diet and lifestyle changes where she significantly lost weight. I also realize that she treats herself a glass of wine with dinner and is down to smoking one pack per day. Your patient shows a strong desire to quit smoking, and Chantix is a viable option for her.
Systemic drugs may work in some cases where topical creams have not made an improvement in the psoriasis. Although the drugs seem to have good effects on widespread psoriasis, the side effects can be more dangerous than the disease itself, and nearly all oral medications require regular blood testing or liver biopsies.
When one is healthy there is hardly a need to visit the doctors, or a need to consistently refill medications. However, when one has an illness, especially an illness that does not have a cure, then one is obligated to go for monthly check-ups, monthly blood draws, and monthly pharmacy visits. Such is the case for Nirmal, a 52-year-old female, who has had rheumatoid arthritis for five years and hypertension since her early thirties. Rheumatoid arthritis is a chronic inflammatory disease, considered an “autoimmune disease,” and is characterized by “joint swelling, joint tenderness,” and destruction of “synovial joints” (Charles, Britt, & Pan, 2013, p. 765). She currently takes a myriad of medications which control her rheumatoid arthritis and hypertension, but the five medications that will be analyzed are: prednisone, gabapentin, methotrexate, metoprolol, and tramadol.
In today’s competitive world where organizations looking for high profitability and market share, consumers have very important role. Companies are looking for capture consumers in order to get larger market share. For this reason organization developed a number of techniques and tools. One of such tools is consumer behavior which has been come from economic theory. Consumer behavior is mainly studying the factors and situations that can affect purchase decisions of consumers. Consumer behavior is being very important discipline of management sciences which help out to understand of customers’ decision making.